Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/17/1993 | DE4141178A1 New nucleic acid sequencing method - using one labelled nucleotide at one time in cycles comprising elongation, wash, label detection and removal of the label, then repeating |
06/17/1993 | DE4138621A1 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg A method for screening substances having a modulating effect on a cellular rezeptorabhaengigen signaluebertragungsweg |
06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
06/16/1993 | EP0547026A1 Gene coding for human colony-stimulating factors |
06/16/1993 | EP0547008A1 New antisense oligonucleotides |
06/16/1993 | EP0546833A2 Calcium-regulated promoter |
06/16/1993 | EP0546813A2 Proteins for inhibiting adhesion of platelets to collagen |
06/16/1993 | EP0546787A2 Expression of specific immunogens using viral antigens |
06/16/1993 | EP0546762A1 Sexing method of bovine embryos |
06/16/1993 | EP0546634A2 Tumor associated monoclonal antibody 88BV59 |
06/16/1993 | EP0546590A1 Detection of amplified nucleic acid using secondary soluble helper oligonucleotides and test kit |
06/16/1993 | EP0546349A2 PRP overproducing haemophilus influenzae strain |
06/16/1993 | EP0546333A1 Cloned DNA having enhancer activity, recombinant vector comprising the same and process for producing gene product using the same |
06/16/1993 | EP0546156A1 Isolation and characterization of a novel protease from streptomyces lividans |
06/16/1993 | EP0546149A1 Nucleotide sequences hybridizable with the nov gene of chickens |
06/16/1993 | EP0546134A1 AMPLIFIER AND SILENCER SEQUENCES ISOLATED FROM THE GPIIb PROMOTER |
06/16/1993 | EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
06/16/1993 | EP0546125A1 Osteogenic factor |
06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
06/16/1993 | EP0546110A1 New insulin-like growth factor binding protein igfbp-5 |
06/16/1993 | EP0546091A1 Homologous recombination in mammalian cells |
06/16/1993 | EP0546090A1 Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases. |
06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
06/16/1993 | EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK |
06/16/1993 | EP0546074A1 Genetic material encoding igfbp-5 |
06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
06/16/1993 | EP0546053A1 Genetic material encoding igfbp-4 |
06/16/1993 | EP0546049A1 A method for rapid selection of efficient secretion vectors. |
06/16/1993 | EP0546045A1 Enzymes with xylanolytic activity. |
06/16/1993 | EP0546022A1 High viscosity bacteria, bacterial compositions, and methods |
06/16/1993 | EP0546016A1 Dna, dna constructs, cells and plants derived therefrom |
06/16/1993 | EP0538412A4 A cdna encoding the rat d 1? dopamine receptor linked to adenylyl cyclase activation and expression product |
06/16/1993 | EP0531436A4 Sequence-specific nonphotoactivated crosslinking agents which bind to the major groove of duplex dna |
06/16/1993 | EP0428519B1 Method for manipulation of the cell types of eukaryotes |
06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
06/16/1993 | EP0192741B1 $i(BACILLUS THURINGIENSIS) CRYSTAL PROTEIN GENE TOXIN SEGMENT |
06/16/1993 | CN1073209A Biosynthesized serine and its related product and process |
06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
06/16/1993 | CN1073161A Endothelin receptor antagonists |
06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
06/15/1993 | US5220014 Inhibit protein synthesis |
06/15/1993 | US5220013 Use of materials related to amyloid protein deposits |
06/15/1993 | US5220007 Cleavage of an RNA molecule followed by excision of the selected target segment |
06/15/1993 | US5220006 Identification of a suppressor of atherogenic apolipoprotein |
06/15/1993 | US5220004 An isolated sequence-specific oligonucleotide probe for determining an individual's genotype with respect to a set of three alleles |
06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
06/15/1993 | US5219994 Anticoagulant glycoprotein |
06/15/1993 | US5219990 Papillomavirus e2 trans-activation repressors |
06/15/1993 | US5219989 Second functional site binds solid support matrix so as to allow first functional site to be immobilized and still remain accessible to interact with cap structure of RNA |
06/15/1993 | US5219759 Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors |
06/15/1993 | US5219753 Genetically engineered microorganisms containing a gene segment coding for a lipase from Rhizopus delemar |
06/15/1993 | US5219748 Recombinant human and rat protein kinase c polypetides |
06/15/1993 | US5219746 Ice-mediated introduction of substances into biological material |
06/15/1993 | US5219740 Genetic engineering for mammalian implants |
06/15/1993 | US5219739 Wound healing agents |
06/15/1993 | US5219738 Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant |
06/15/1993 | US5219737 Culturing Escherichia; used to measure ATP in a colored solution, such as blood |
06/15/1993 | US5219732 Antibody-mediated cofactor-driven reactions |
06/15/1993 | US5219727 Quantitation of nucleic acids using the polymerase chain reaction |
06/15/1993 | US5219726 Physical mapping of complex genomes |
06/15/1993 | US5219725 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
06/15/1993 | US5219569 Protease resistant urokinase |
06/15/1993 | CA1319120C Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
06/14/1993 | CA2083542A1 Tumor associated monoclonal antibody 88bv59 |
06/13/1993 | CA2085089A1 Immunological detection method |
06/12/1993 | CA2084180A1 Expression of specific immunogens using viral antigens |
06/12/1993 | CA2057387A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
06/11/1993 | CA2084834A1 Proteins for inhibiting adhesion of platelets to collagen |
06/10/1993 | WO1995011315A1 Packaging of reaction components in wax for release under specified temperature conditions |
06/10/1993 | WO1993011265A1 Method for generating chromosome region-specific probes |
06/10/1993 | WO1993011257A2 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path |
06/10/1993 | WO1993011254A1 Protease-stable proteins |
06/10/1993 | WO1993011252A1 Cloning vectors for expressing pcr generated variable regions as complete heavy and/or light chain(s) |
06/10/1993 | WO1993011251A1 Recombinant viruses comprising artificial proteolytic cleavage site |
06/10/1993 | WO1993011250A1 Bicistronic viruses |
06/10/1993 | WO1993011249A1 A method of cloning proteins in yeast and cellulase from humicola insolens |
06/10/1993 | WO1993011248A1 Production of proteins using 7b2 protein |
06/10/1993 | WO1993011247A1 Prohormone convertase transformed cells |
06/10/1993 | WO1993011246A1 Novel proteases with dna fragmenting activity |
06/10/1993 | WO1993011245A1 Fatty acid desaturase genes from plants |
06/10/1993 | WO1993011244A1 Cyclic di-guanylate metabolic enzymes |
06/10/1993 | WO1993011243A1 MAIZE ACETYL CoA CARBOXYLASE ENCODING DNA CLONES |
06/10/1993 | WO1993011242A1 Method for selecting recombinant micro-organisms of which the surface comprises at least one molecule having enzymatic activity |
06/10/1993 | WO1993011241A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
06/10/1993 | WO1993011240A1 Method for refolding igf-i to active conformation |
06/10/1993 | WO1993011239A1 New thrombin-inhibiting proteins from terrestrial leeches |
06/10/1993 | WO1993011238A1 Humanized b-b10, an anti-il2 receptor antibody |
06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |
06/10/1993 | WO1993011236A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
06/10/1993 | WO1993011235A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
06/10/1993 | WO1993011234A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
06/10/1993 | WO1993011233A1 Dna fragment which codes for tumor cell proliferation inhibiting factor |
06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine |
06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
06/10/1993 | WO1993011230A1 Modified mammalian stem cell blocking viral replication |
06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment |
06/10/1993 | WO1993011227A1 Recombinant poly(a) polymerase |
06/10/1993 | WO1993011223A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
06/10/1993 | WO1993011221A1 Device and process for isolating and purifying nucleic acids |